Abstract：Objective To study the changes of platelet function and its effect on thrombosis in patients with essential thrombocytosis (ET), and to analyze the effect of Sodium Ozagrel on thrombosis prevention. Methods Thirty-two patients with ET admitted to Shaanxi Provincial People′s Hospital ("our hospital" for short) from September 2014 to September 2017 were enrolled as the study object, and they were divided into two groups by random number table, 16 cases in each group. Patients in routine group were treated with routine therapy, while patients in study group were treated with Ozagrel Sodium on the basis of routine treatment. Another 20 healthy volunteers who received physical examination in our hospital during the same period were selected as control group. The levels of P-selectin (CD62P), anti-fibrinogen receptor monoclonal antibody (PAC-1), thromboxane B2 (TXB2), 6-keto-prostaglandin F1α (6-keto-PGF1α) and thrombosis rate of three groups were observed. Results Before treatment, there were no differences in levels of CD62P, PAC-1, TXB2 and 6-keto-PGF1α between the routine group and study group (P > 0.05), but they were significantly higher than those of the control group, the differences were statistically significant (P < 0.05). After treatment, the levels of CD62P, PAC-1, TXB2 and 6-keto-PGF1α in the study group were significantly lower than those in the routine group, but still higher than those in the control group, the differences were statistically significant (P < 0.05). The thrombosis rate in the study group was only 6.25%, which was significantly lower than 18.75% in the control group, the difference was statistically significant (P < 0.05). Conclusion The indexes of platelet function and activity in ET patients are significantly different from those in healthy person, and the incidence of thrombosis is significantly increased. Sodium Ozagrel can significantly improve the platelet status of ET patients, promote the therapeutic effect and reduce the incidence of thrombosis, which is worthy of clinical application and promotion.
李岚 高瑛 张维华 侯丽敏 高秋英. 原发性血小板增多症对血小板功能和血栓形成的影响及奥扎格雷钠预防血栓的临床效果[J]. 中国医药导报, 2019, 16(20): 145-147,151.
LI Lan GAO Ying ZHANG Weihua HOU Limin GAO Qiuying. Effects of primary thrombocytosis on platelet function and thrombus formation and the clinical effect of Sodium Ozagrel in preventing thrombus. 中国医药导报, 2019, 16(20): 145-147,151.
2019, Vol. 16 
京公网安备 11010502046598号